|
Mr. Lorenz Muller currently serves as the head of Marketing, having held various positions since joining CV Therapeutics in 2001. He has played a critical role in the growth and development of the Marketing function, as well as in the approval and launch of Ranexa®. Mr. Muller oversees scientific, brand, and customer marketing, as well as business analytics. He is also actively involved in evaluating product partnership/alliance opportunities for CVT that would complement the commercialization of products developed from CVT's R&D activities.
Before joining CV Therapeutics, Mr. Muller spent six years with Merck & Co., Inc. in various sales and marketing positions, including product management as part of the hypertension and heart failure business group. He has also worked at Genentech in strategic marketing planning and served as a consultant for Arthur D. Little, Inc. for five years, completing technology-based consulting assignments for a large number of biotechnology, pharmaceutical, and fine chemical clients.
Mr. Muller received a BS in both chemical engineering and life sciences and his MS in chemical engineering from the Massachusetts Institute of Technology. He received his MBA from the Harvard Graduate School of Business Administration. | 